Home » Newsletters » BioWorld Asia

BioWorld Asia

April 24, 2000

View Archived Issues

Antisoma Stock Takes Hit Following Independent Study

CeNeS Buying Cambridge Neuro In All-Stock Deal Valued At $44M

Study Of Rare Disorder Provides Clues For New Cancer Therapies

French Researchers Say There Are Only About 30,000 Genes

Oxford GlycoSciences Issued Broad Patent On Proteomics

NicOx Reports Early Phase II Results, Starts Phase I Study

Watson, Arntzen Among Those Adding Input To Israeli Biotech

SkyePharma Changes Strategy, Plans More Development Work

ExonHit, Collaborators Identify Markers Linked To Hypoxia

Queensland Group Develops Genetic Test For Skin Cancer

Other News To Note

United Nations Takes Step Toward Labeling GM Food